Abstract:Objectives Adipose-derived stromal cells (ADSCs) transplantation has been demonstrated a promising therapy for peripheral arterial disease (PAD). However, the underlying mechanism of ADSCs9 potential efficacy remains uncertain. The current study aimed to investigate the long-term outcome and therapeutic behaviour of engrafted ADSCs in a murine PAD model by multimodality molecular imaging. Methods ADSCs were isolated from C57BL/6 trangenic mice that constitutively express dual-reporter firefly luciferase and green fluorescent protein (Fluc+-GFP+). PAD model was constructed by unilateral femoral artery ligation. Male syngenetic BALB/c nude mice (n=90) were randomised into 3 groups receiving the following: (1) sham-operation+phosphate-buffered saline (PBS); (2) PAD+PBS; (3) PAD+ADSCs (1×107, intramuscular injection). Long-term fate of ADSCs in vivo was monitored by bioluminescence imaging (BLI), and bioluminescence tomography with micro-CT (BLT/micro-CT), further validated by immunofluorescence staining. Hindlimb perfusion and angiogenesis were measured by in vivo laser Doppler perfusion imaging (LDPI) and micro-CT angiography, which were confirmed by vascular casting with scanning electron microscopy (SEM), immunohistochemistry and functional scores. Therapeutic signal pathways and angiogenic cytokines was assessed by Western blot and ELISA. Results A short-lived survival (∼5 weeks) of post-transplant ADSCs within the ischaemic hindlimb was longitudinally followed by noninvasive BLI/BLT/micro-CT, which enabled quantitative 3-dimensional (3D) imaging for the cells9 location and kinetics in vivo. ADSCs could improve the blood perfusion recovery, ambulatory function and prognosis of the ischaemic hindlimb by inducing angiogenesis. ADSCs didn9t incorporate into host microvasculature network, but were associated with an activation of vascular endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2), the mammalian target of rapamycin (mTOR) and Akt. Inhibition of VEGF, mTOR or Akt could suppress ADSCs-stimulated perfusion restoration. Conclusions In vivo 3D multimodality imaging facilitates tracking the functional survival of transplanted ADSCs in PAD model. ADSCs may amplify the pro-angiogenic signal partly via VEGF/mTOR/Akt pathway and improve hindlimb ischaemia.

Abstract 17: The Comparison of Adipose Derived Regenerative Cells and Bone Marrow Mononuclear Cells as Transplanted Cells for Therapeutic Angiogenesis

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

[Therapeutic Neovascularization with Autologous Bone Marrow CD34+ Cells Transplantation in Hindlimb Ischemia].

No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy

Abstract 723: Agonist of Growth Hormone Releasing Hormone Enhances Angiogenic Therapy by Mesenchymal Stem Cells

Dynamic Imaging of Allogeneic Adipose-Derived Regenerative Cells Transplanted in Ischemic Hind Limb of Apolipoprotein E Mouse Model.

Novel cell therapy with ex vivo cultured peripheral blood mononuclear cells significantly impacts angiogenesis in the murine ischemic limb model

Adipose stromal cell and sarpogrelate orchestrate the recovery of inflammation-induced angiogenesis in aged hindlimb ischemic mice.

Abstract 3667: Hypoxic Preconditioning of Mononuclear Cells Enhances Angiogenesis by Increasing Their Retention after Implantation into Ischemic Tissue

Adipose-Derived Stromal Cells Amplify the Angiogenic Signal Via Vegf/Mtor/Akt Pathway in the Murine Peripheral Arterial Disease Model: an in Vivo 3d Multimodality Imaging Study

Adipose Stromal Cells Amplify Angiogenic Signaling Via The Vegf/Mtor/Akt Pathway In A Murine Hindlimb Ischemia Model: A 3d Multimodality Imaging Study

Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model

Abstract 606: Ischemic Rescue by Transplantation of Vascular Progenitor Cells Isolated from Fat

Comparison of Revascularization of Bone Marrow Mononuclear Cells and Endothelial Progenitor Cells Transplantation

Adipose-derived regenerative cells as a promising therapy for cardiovascular diseases: an overview

Superiority of Adipose-derived CD34 + Cells over Adipose-derived Stem Cells in Promoting Ischemic Tissue Survival

Allogeneic Adipose-Derived Mesenchymal Stem Cell Transplantation Alleviates Atherosclerotic Plaque by Inhibiting Ox-LDL Uptake, Inflammatory Reaction and Endothelial Damage in Rabbits

[Upregulating the Expression of Angiogenesis-Related Genes by Transplanting Autologous Mononuclear Bone Marrow Cells into Myocardial Infarction Scar and the Periphery].

Transplantation of adipose tissue-derived stem cells overexpressing heme oxygenase-1 improves functions and remodeling of infarcted myocardium in rabbits.

Therapeutic Neovascularization by Autologous Transplantation with Expanded Endothelial Progenitor Cells from Peripheral Blood into Ischemic Hind Limbs

Angiogenesis and bone regeneration by allogeneic mesenchymal stem cell intravenous transplantation in rabbit model of avascular necrotic femoral head.